CDPYF(CDPYF)
CDPYF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.01B | $1.03B | $1.05B | $1.36B |
| Low | $994M | $1.02B | $1.04B | $1.34B |
| High | $1.02B | $1.05B | $1.07B | $1.38B |
| EBITDA Avg | $398M | $407M | $417M | $537M |
| Low | $393M | $403M | $413M | $531M |
| High | $404M | $414M | $424M | $545M |
| EBIT Avg | $387M | $396M | $406M | $523M |
| Low | $383M | $393M | $402M | $517M |
| High | $393M | $403M | $412M | $531M |
| Net Income Avg | $85M | $288M | — | — |
| Low | $84M | $284M | — | — |
| High | $87M | $294M | — | — |
| EPS Avg | $0.73 | $2.49 | — | — |
| Low | $0.72 | $2.45 | — | — |
| High | $0.75 | $2.54 | — | — |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 6 / — | 7 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $253M | $254M | $254M | $255M | $257M | $259M | $260M |
| Low | $251M | $252M | $251M | $253M | $255M | $257M | $258M |
| High | $256M | $256M | $256M | $257M | $260M | $262M | $263M |
| EBITDA Avg | $100M | $100M | $100M | $101M | $102M | $103M | $103M |
| Low | $99M | $100M | $99M | $100M | $101M | $102M | $102M |
| High | $101M | $101M | $101M | $102M | $103M | $103M | $104M |
| EBIT Avg | $98M | $98M | $98M | $98M | $99M | $100M | $100M |
| Low | $97M | $97M | $97M | $97M | $98M | $99M | $99M |
| High | $98M | $99M | $99M | $99M | $100M | $101M | $101M |
| Net Income Avg | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |